BWM
MRNA icon

Baystate Wealth Management’s Moderna MRNA Stock Holding History

Baystate Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.98K Buy
+30
New +$2.52K ﹤0.01% 997
2023
Q1 		– Sell
-5
Closed -$1K – 1062
2022
Q4 		$1K Buy
+5
New +$818 ﹤0.01% 880
2021
Q3 		– Sell
-33
Closed -$8K – 869
2021
Q2 		$8K Hold
33
– – ﹤0.01% 526
2021
Q1 		$4K Hold
33
– – ﹤0.01% 531
2020
Q4 		$3K Hold
33
– – ﹤0.01% 536
2020
Q3 		$2K Buy
+33
New +$2.3K ﹤0.01% 541

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baystate Wealth Management's MRNA Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in Moderna (MRNA) in Q4 2023: 30 shares worth $2.98K. The stake represents ﹤0.01% of the portfolio and ranks #997 among its holdings. This is a return to the name: Baystate Wealth Management previously reported a position in MRNA as recently as Q4 2022.

Baystate Wealth Management first reported a position in MRNA in Q3 2020 and has held it in 6 quarters since. The position peaked at $8K in Q2 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Baystate Wealth Management held 30 shares of Moderna worth $2.98K as of Q4 2023.
  • Moderna was a new Baystate Wealth Management position in Q4 2023.
  • Moderna made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #997 holding.
  • Baystate Wealth Management first reported a position in Moderna in Q3 2020 and has held it in 6 quarters since.
  • Baystate Wealth Management's Moderna position peaked at $8K in Q2 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.